Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)
Clinical trial NCT06357988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06357988
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-20
- Primary completion
- 2022-11-04
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.